Preview

Pharmacokinetics and Pharmacodynamics

Advanced search

The pilot study of the basic pharmacokinetic properties of pyrrolylcarnosine — the new pyrrolic derivative of dipeptide carnosine

https://doi.org/10.37489/2587-7836-2023-2-29-36

Abstract

The experimental study of the pharmacokinetic characteristics of a new pyrrole derivative of carnosine, pyrrolylcarnosine, was carried out. Based on the results of the experiment, the basic pharmacokinetic parameters of the drug are expected. The tissues and organs bioavailability was studied. The tropism of pyrrolylcarnosine to the organs of elimination and the ability of pyrrolylcarnosine to penetrate into the heart muscle tissue were shown.

About the Authors

D. A. Abaimov
Research Center of Neurology
Russian Federation

Denis A. Abaimov - PhD, Cand. Sci. (Biology), Senior Researcher at the Laboratory of Hemorheology, Hemostasis and Pharmacokinetics with clinical and laboratory diagnostics

Moscow



Anastasiya V. Khutorova
Research Center of Neurology; Lomonosov Moscow State University
Russian Federation

Anastasiya V. Khutorova - laboratory assistant-researcher of the Laboratory of Experimental and Translational Neurochemistry; 

postgraduate student of the Department of Pharmacology of the Faculty of Fundamental Medicine

Moscow



A. K. Sariev
FSAEI HE I. M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenovskiy University)
Russian Federation

Abrek K. Sariev - Dr. Sci (Med.), Professor, Leading Researcher, Laboratory of Pharmacokinetics and Metabolomic Analysis

Moscow



O. I. Kulikova
Research Center of Neurology
Russian Federation

Olga I. Kulikova - PhD, Cand. Sci. (Biology), Researcher at the Laboratory of Experimental and Translational Neurochemistry

Moscow



M. A. Belousova
Lomonosov Moscow State University
Russian Federation

Margarita A. Belousova - PhD, Cand. Sci. (Med), Researcher of the Department of Pharmacology of the Faculty of Fundamental Medicine

Moscow



S. L. Stvolinsky
Research Center of Neurology
Russian Federation

Sergey L. Stvolinsky - Dr. Sci (Biology), Leading Researcher at the Laboratory of Experimental and Translational Neurochemistry

Moscow



V. A. Migulin
N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences
Russian Federation

Vasily A. Migulin - PhD, Cand. Chemical Sci., Researcher at the Laboratory of Heterocyclic Compounds

Moscow



T. N. Fedorova
Research Center of Neurology
Russian Federation

Tatiana N. Fedorova - Dr. Sci (Biology), Chief Researcher, Head of the Laboratory of Experimental and Translational Neurochemistry

Moscow



References

1. Berezhnoy DS, Stvolinsky SL, Lopachev AV, et al. Carnosine as an effective neuroprotector in brain pathology and potential neuromodulator in normal conditions. Amino Acids. 2019 Jan;51(1):139–150. DOI: 10.1007/s00726-018-2667-7.

2. Boldyrev AA, Aldini G, Derave W. Physiology and pathophysiology of carnosine. Physiol Rev. 2013 Oct;93(4):1803–45. DOI: 10.1152/physrev.00039.2012.

3. Bhardwaj V, Gumber D, Abbot V, Dhiman S, Sharma P. Pyrrole: a resourceful small molecule in key medicinal hetero-aromatics. Rsc Advances. 2015;5(20):15233–15266. DOI:10.1039/C4RA15710A

4. Каратеев А. Е. На пути к созданию новой генерации нестероидных противовоспалительных препаратов: амтолметин гуацил. Современная ревматология. 2014;(2):72–78. [Karateev AE. On the way toward designing next-generation nonsteroidal anti-inflammatory drugs: amtolmetin guacil. Sovremennaya revmatologiya = Modern Rheumatology Journa. 2014;(2):72–78. (In Russ).]. doi: 10.14412/1996-7012-2014-2-83-89.

5. Матвеев А.В., Крашенинников А.Е., Егорова Е.А. Современный взгляд на эффективность и безопасность кеторолака. РМЖ. Медицинское обозрение. 2018;(4):34–39. [Matveev AV, Krasheninnikov AE, Egorova EA. Modern view on the efficacy and safety of ketorolac. RMJ. Medical Review. 2018;(4):34–39. (In Russ).].

6. Солгалова А.С., Солдатов В.О., Першина М.А., Покровская Т.Г. Пирацетам и бетагистин: возможные механизмы эндотелиопротекции. Человек и его здоровье. 2018;(2):61–69. [Solgalova AS, Soldatov VO, Pershina MA, Pokrovskaya TG. Piracetam and betahistine: possible mechanisms of endothelioprotection. Humans and their health. 2018;(2):61–69. (In Russ).]. DOI: 10.21626/vestnik/2018-2/10.

7. Hanuman Reddy V, Mallikarjuna Reddy G, Thirupalu Reddy M, Rami Reddy YV. Microwave-assisted facile synthesis of trisubstituted pyrrole derivatives. Research on Chemical Intermediates. 2015;41:9805–9815. DOI: 10.1007/s11164-015-1966-9.

8. Tzankova D, Vladimirova S, Peikova L, Georgieva M. Synthesis of pyrrole and substituted pyrroles. Journal of Chemical Technology and Metallurgy. 2018;53(3):451–464. DOI: 10.2478/acph-2020-0026.

9. Патент 2 777 391 C1 Российская Федерация, МПК C07D403/12 A61K31/4178 A61P39/06 A61P25/00. Средство, обладающее антиоксидантной и нейропротекторной активностью. Заявитель и патентообладатель ФГБНУ НЦН. – № 2021133431; заявл. 17.11.2021; опубл. 03.08.2022; Бюл.№23. [Fedorova TN, Stvolinsky SL, Migulin VA, et al, inventors; SUBSTANCE WITH ANTIOXIDANT AND NEUROPROTECTOR ACTIVITY. Russia patent RU 2777391 C1., 2022. (In Russ).]. URL: https://patenton.ru/patent/RU2777391C1

10. Pegova A, Abe H, Boldyrev A. Hydrolysis of carnosine and related compounds by mammalian carnosinases. Comp Biochem Physiol B Biochem Mol Biol. 2000 Dec;127(4):443–6. DOI: 10.1016/s0305-0491(00)00279-0.

11. Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ / Под общей редакцией члена-корреспондента РАМН, профессора Р. У. Хабриева. 2-изд., перераб. и доп. М.: ОАО «Издательство «Медицина», 2005. 832 с. [Rukovodstvo po eksperimental'nomu (doklinicheskomu) izucheniyu novyh farmakologicheskih veshchestv. Under the general editorship of corresponding member of the Russian Academy of Sciences, Professor RU Khabriev. 2nd ed., reprint. and additional. Moscow: JSC "Publishing House "Medicine", 2005. (In Russ).].

12. Основы фармакокинетики / И.И. Мирошниченко. Москва: ГЭОТАР-МЕД, 2002 (ООО Момент) 185 с. [Miroshnichenko II. Osnovy farmakokinetiki. GEOTAR-Media, 2002. (In Russ).].

13. Фармакокинетика / Н.Н. Каркищенко, В.В. Хоронько, С.А. Сергеева, В.Н. Каркищенко; Под. ред. Г.И. Должич. Ростов-на-Дону: Феникс, 2001. 381 с. [Farmakokinetika. Karkishchenko NN, Khoronko VV, Sergeeva SA, Karkishchenko VN. / Ed by Dolzhich GI. Rostov-on-Don: Phoenix; 2001. (In Russ).].

14. Тюренков И.Н., Перфилова В.Н., Смирнова Л.А., и др. Фармакокинетические свойства нового производного ГАМК цитрокарда: распределение и тканевая биодоступность. Фармакокинетика и Фармакодинамика. 2012;(2):26–29. [Tyurenkov IN, Perfilova VN, Smirnova LA, et al. Pharmacokinetic properties of a new GABA citrocard derivative: distribution and tissue bioavailability. Farmakokinetika i farmakodinamika = Pharmacokinetics and pharmacodynamics. 2012;(2):26-29. (In Russ).]. DOI: 10.30906/0869-2092-2013-76-3-38-40.


Review

For citations:


Abaimov D.A., Khutorova A., Sariev A.K., Kulikova O.I., Belousova M.A., Stvolinsky S.L., Migulin V.A., Fedorova T.N. The pilot study of the basic pharmacokinetic properties of pyrrolylcarnosine — the new pyrrolic derivative of dipeptide carnosine. Pharmacokinetics and Pharmacodynamics. 2023;(2):29-36. (In Russ.) https://doi.org/10.37489/2587-7836-2023-2-29-36

Views: 445


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2587-7836 (Print)
ISSN 2686-8830 (Online)